-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Nanobiotix, Raises Price Target to $36

Benzinga·04/02/2026 14:09:22
Listen to the news
Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the price target from $26 to $36.